Meddenovo Drug Design

Company profile

Meddenovo Drug Design company profile

Meddenovo is an AI company pioneering the design of next-generation peptide therapeutics. Our platform creates novel cyclic peptides from scratch, combining advanced artificial intelligence with deep molecular understanding. These molecules can reach complex targets that small molecules or antibodies cannot, offering new possibilities for treating cancer and other diseases. We bring together science, computation, and creativity to design precise, stable, and effective candidates within weeks instead of months. Our technology is already being applied in collaboration with leading pharmaceutical partners to accelerate discovery and reduce development risk. Meddenovo’s mission is to make intelligent drug design accessible to every scientist, turning complex discovery processes into simple, insightful decisions that bring better medicines to patients faster.